nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—AGTR1—Allograft Rejection—MICA—Behcet's disease	0.156	0.156	CbGpPWpGaD
Valsartan—AGTR1—Peptide GPCRs—CCR1—Behcet's disease	0.0653	0.0653	CbGpPWpGaD
Valsartan—AGTR1—ACE Inhibitor Pathway—NOS3—Behcet's disease	0.06	0.06	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—CTLA4—Behcet's disease	0.0366	0.0366	CbGpPWpGaD
Valsartan—ALB—Scavenging of heme from plasma—APOA1—Behcet's disease	0.0329	0.0329	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—CCR1—Behcet's disease	0.0307	0.0307	CbGpPWpGaD
Valsartan—ALB—HDL-mediated lipid transport—APOA1—Behcet's disease	0.0293	0.0293	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IL10—Behcet's disease	0.0285	0.0285	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—HLA-B—Behcet's disease	0.0271	0.0271	CbGpPWpGaD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—Behcet's disease	0.0253	0.0253	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.0241	0.0241	CbGpPWpGaD
Valsartan—ALB—Lipoprotein metabolism—APOB—Behcet's disease	0.0213	0.0213	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.0206	0.0206	CbGpPWpGaD
Valsartan—ALB—Lipoprotein metabolism—APOA1—Behcet's disease	0.0168	0.0168	CbGpPWpGaD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOB—Behcet's disease	0.0166	0.0166	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CCR1—Behcet's disease	0.0157	0.0157	CbGpPWpGaD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—Behcet's disease	0.0156	0.0156	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—CXCL8—Behcet's disease	0.0156	0.0156	CbGpPWpGaD
Valsartan—ALB—Lipid and lipoprotein metabolism—APOB—Behcet's disease	0.0141	0.0141	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—APOB—Behcet's disease	0.0139	0.0139	CbGpPWpGaD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—Behcet's disease	0.0131	0.0131	CbGpPWpGaD
Valsartan—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—Behcet's disease	0.0124	0.0124	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—CAT—Behcet's disease	0.0117	0.0117	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—APOB—Behcet's disease	0.0113	0.0113	CbGpPWpGaD
Valsartan—ALB—Lipid and lipoprotein metabolism—APOA1—Behcet's disease	0.0112	0.0112	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—APOA1—Behcet's disease	0.011	0.011	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—TNF—Behcet's disease	0.0108	0.0108	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—ICAM1—Behcet's disease	0.0105	0.0105	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—CAT—Behcet's disease	0.00926	0.00926	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—APOB—Behcet's disease	0.00899	0.00899	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—APOA1—Behcet's disease	0.00896	0.00896	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CCR1—Behcet's disease	0.00887	0.00887	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.00874	0.00874	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—ICAM1—Behcet's disease	0.00851	0.00851	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCR1—Behcet's disease	0.00806	0.00806	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—CXCL8—Behcet's disease	0.00771	0.00771	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—APOA1—Behcet's disease	0.00768	0.00768	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.00732	0.00732	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—APOA1—Behcet's disease	0.00712	0.00712	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—SERPINE1—Behcet's disease	0.00711	0.00711	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.00676	0.00676	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—SERPINE1—Behcet's disease	0.0061	0.0061	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00581	0.00581	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.00565	0.00565	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.00526	0.00526	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.00517	0.00517	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—TNF—Behcet's disease	0.00515	0.00515	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—APOB—Behcet's disease	0.005	0.005	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCR1—Behcet's disease	0.00476	0.00476	CbGpPWpGaD
Valsartan—ALB—Hemostasis—ITGB2—Behcet's disease	0.00447	0.00447	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TNF—Behcet's disease	0.00419	0.00419	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.00416	0.00416	CbGpPWpGaD
Valsartan—ALB—Hemostasis—ITGAL—Behcet's disease	0.00403	0.00403	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.00396	0.00396	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CXCL8—Behcet's disease	0.00394	0.00394	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.00354	0.00354	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.00341	0.00341	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.00336	0.00336	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—Behcet's disease	0.00333	0.00333	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.0028	0.0028	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.0027	0.0027	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.00266	0.00266	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CAT—Behcet's disease	0.00241	0.00241	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOB—Behcet's disease	0.00234	0.00234	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOB—Behcet's disease	0.00225	0.00225	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCL8—Behcet's disease	0.00223	0.00223	CbGpPWpGaD
Valsartan—ALB—Hemostasis—APOB—Behcet's disease	0.00222	0.00222	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL8—Behcet's disease	0.00202	0.00202	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.00202	0.00202	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—APOB—Behcet's disease	0.00192	0.00192	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOA1—Behcet's disease	0.00185	0.00185	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOA1—Behcet's disease	0.00178	0.00178	CbGpPWpGaD
Valsartan—ALB—Hemostasis—APOA1—Behcet's disease	0.00176	0.00176	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.00165	0.00165	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CAT—Behcet's disease	0.00162	0.00162	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.0016	0.0016	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOB—Behcet's disease	0.00157	0.00157	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.00152	0.00152	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SERPINE1—Behcet's disease	0.00141	0.00141	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NOS3—Behcet's disease	0.00141	0.00141	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SERPINE1—Behcet's disease	0.00139	0.00139	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOS3—Behcet's disease	0.00135	0.00135	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS3—Behcet's disease	0.00133	0.00133	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.00131	0.00131	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOA1—Behcet's disease	0.00125	0.00125	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL8—Behcet's disease	0.00119	0.00119	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NOS3—Behcet's disease	0.000944	0.000944	CbGpPWpGaD
Valsartan—ALB—Metabolism—CAT—Behcet's disease	0.000927	0.000927	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOB—Behcet's disease	0.0009	0.0009	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CAT—Behcet's disease	0.000759	0.000759	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOB—Behcet's disease	0.000736	0.000736	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOA1—Behcet's disease	0.000712	0.000712	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOA1—Behcet's disease	0.000583	0.000583	CbGpPWpGaD
Valsartan—ALB—Metabolism—NOS3—Behcet's disease	0.000539	0.000539	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NOS3—Behcet's disease	0.000442	0.000442	CbGpPWpGaD
